FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Brian Findlay

Research Profile

Procedures

Disorders

Concepts & Ideas

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Kathleen I Pritchard; Lois E Shepherd; Ted A Vandenberg; D Walde; Timothy J Whelan; Carolyn F Wilson; Jacques Cantin; Judith-Anne W Chapman; Susan F Dent; Brian Findlay; Paul E Goss; Lei Han; Brian D Norris; Susan E O'Reilly; Ettie Piura; Michael N Pollak
Randomized trial of tamoxifen versus combined tamoxifen and octreotide LAR Therapy in the adjuvant treatment of early-stage breast cancer in postmenopausal women: NCIC CTG MA.14.
Brian Findlay; Katia S Tonkin; M Crump; B Norris; M Trudeau; Martin E Blackstein; M Burnell; JR Skillings; D Bowman; D Walde; M Levine; K I Pritchard; Michael J Palmer; Dongsheng Tu; L Shepherd
A dose escalation trial of adjuvant cyclophosphamide and epirubicin in combination with 5-fluorouracil using G-CSF support for premenopausal women with breast cancer involving four or more positive nodes.
Andrew M Arnold; Lesley Seymour; Michael Smylie; Keyue Ding; Yee C Ung; Brian Findlay; Christopher W Lee; Marina Djurfeldt; Marlo Whitehead; Peter Ellis; Glenwood Goss; Adrien Chan; Jacinta Meharchand; Yasmin Alam; Richard Gregg; Charles Butts; Peter Langmuir; Frances A Shepherd
Phase II study of vandetanib or placebo in small-cell lung cancer patients after complete or partial response to induction chemotherapy with or without radiation therapy: National Cancer Institute of Canada Clinical Trials Group Study BR.20.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Brian Findlay (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Kathleen I Pritchard; Lois E Shepherd; Ted A Vandenberg; D Walde; Timothy J Whelan; Carolyn F Wilson; Jacques Cantin; Judith-Anne W Chapman; Susan F Dent; Brian Findlay; Paul E Goss; Lei Han; Brian D Norris; Susan E O'Reilly; Ettie Piura; Michael N Pollak
Randomized trial of tamoxifen versus combined tamoxifen and octreotide LAR Therapy in the adjuvant treatment of early-stage breast cancer in postmenopausal women: NCIC CTG MA.14.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(29):3869-76.
2007: Brian Findlay; Katia S Tonkin; M Crump; B Norris; M Trudeau; Martin E Blackstein; M Burnell; JR Skillings; D Bowman; D Walde; M Levine; K I Pritchard; Michael J Palmer; Dongsheng Tu; L Shepherd
A dose escalation trial of adjuvant cyclophosphamide and epirubicin in combination with 5-fluorouracil using G-CSF support for premenopausal women with breast cancer involving four or more positive nodes.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(10):1646-51.
2007: Andrew M Arnold; Lesley Seymour; Michael Smylie; Keyue Ding; Yee C Ung; Brian Findlay; Christopher W Lee; Marina Djurfeldt; Marlo Whitehead; Peter Ellis; Glenwood Goss; Adrien Chan; Jacinta Meharchand; Yasmin Alam; Richard Gregg; Charles Butts; Peter Langmuir; Frances A Shepherd
Phase II study of vandetanib or placebo in small-cell lung cancer patients after complete or partial response to induction chemotherapy with or without radiation therapy: National Cancer Institute of Canada Clinical Trials Group Study BR.20.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(27):4278-84.
2006: Edith A Perez; Robert G Josse; Kathleen I Pritchard; James N Ingle; Silvana Martino; Brian Findlay; Tamara N Shenkier; Richard G Tozer; Michael J Palmer; Lois E Shepherd; Shifang Liu; Dongsheng Tu; Paul E Goss
Effect of letrozole versus placebo on bone mineral density in women with primary breast cancer completing 5 or more years of adjuvant tamoxifen: a companion study to NCIC CTG MA.17.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(22):3629-35.
2005: Frances A Shepherd; José Rodrigues Pereira; tudor ciuleanu; Eng Huat Tan; Vera Hirsh; Sumitra Thongprasert; Daniel Campos; Savitree Maoleekoonpiroj; Michael Smylie; Renato Martins; Maximiliano van Kooten; Mircea Dediu; Brian Findlay; Dongsheng Tu; Dianne Johnston; Andrea Bezjak; Gary Clark; Pedro Santabárbara; Lesley Seymour
Erlotinib in previously treated non-small-cell lung cancer.
The New England journal of medicine 2005;353(2):123-32.
2003: Cesare Gridelli; Ciro Gallo; Frances A Shepherd; Alfonso Illiano; Francovito Piantedosi; Sergio Federico Robbiati; Luigi Manzione; Santi Barbera; Luciano Frontini; Enzo Veltri; Brian Findlay; Silvio Cigolari; Robert Myers; Giovanni Pietro Ianniello; Vittorio Gebbia; Giampietro Gasparini; Sergio Fava; Vera Hirsh; Andrea Bezjak; Lesley Seymour; Francesco Perrone
Gemcitabine plus vinorelbine compared with cisplatin plus vinorelbine or cisplatin plus gemcitabine for advanced non-small-cell lung cancer: a phase III trial of the Italian GEMVIN Investigators and the National Cancer Institute of Canada Clinical Trials Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(16):3025-34.
2000: BD Norris; Kathleen I Pritchard; K James; J Myles; K Bennett; S Marlin; JR Skillings; Brian Findlay; Theodore A Vandenberg; P Goss; Jean Latreille; Leona Rudinskas; WS Lofters; Maureen Trudeau; David Osoba; A Rodgers
Phase III comparative study of vinorelbine combined with doxorubicin versus doxorubicin alone in disseminated metastatic/recurrent breast cancer: National Cancer Institute of Canada Clinical Trials Group Study MA8.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(12):2385-94.
1998: Mark N Levine; Vivien H C Bramwell; Kathleen I Pritchard; BD Norris; Lois E Shepherd; Hakam Abu-Zahra; Brian Findlay; David Warr; D Bowman; J Myles; Andrew Arnold; Theodore A Vandenberg; R MacKenzie; J Robert; Jon Ottaway; M Burnell; C K Williams; Dongsheng Tu
Randomized trial of intensive cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer. National Cancer Institute of Canada Clinical Trials Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(8):2651-8.
1998: Jean Latreille; Joseph L Pater; D Johnston; Francis Laberge; D Stewart; JJ Rusthoven; Paul J Hoskins; Brian Findlay; E McMurtrie; Louise Yelle; C Williams; D Walde; S Ernst; H Dhaliwal; David Warr; Frances A Shepherd; D Mee; L Nishimura; David Osoba; Benny Zee
Use of dexamethasone and granisetron in the control of delayed emesis for patients who receive highly emetogenic chemotherapy. National Cancer Institute of Canada Clinical Trials Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(3):1174-8.
1997: Gordon Okawara; JJ Rusthoven; Toni Newman; Brian Findlay; W Evans
Unresected stage III non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group.
Cancer prevention & control : CPC = Prévention & contrôle en cancérologie : PCC 1997;1(3):249-59.
1997: H W Hirte; D Miller; Katia S Tonkin; Brian Findlay; Valerie Capstick; J Murphy; R Buckman; J Carmichael; M Levine; W Hill
A randomized trial of paracentesis plus intraperitoneal tumor necrosis factor-alpha versus paracentesis alone in patients with symptomatic ascites from recurrent ovarian carcinoma.
Gynecologic oncology 1997;64(1):80-7.
1994: Malcolm J Moore; David Osoba; K Murphy; Ian F Tannock; A Armitage; Brian Findlay; C Coppin; A Neville; P Venner; J Wilson
Use of palliative end points to evaluate the effects of mitoxantrone and low-dose prednisone in patients with hormonally resistant prostate cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(4):689-94.
1993: Mark N Levine; Vivien H C Bramwell; K Pritchard; D Perrault; Brian Findlay; Hakam Abu-Zahra; David Warr; Andrew Arnold; J Skillings
The Canadian experience with intensive fluorouracil, epirubicin and cyclophosphamide in patients with early stage breast cancer.
Drugs 1993;45 Suppl 2():51-9; discussion 58-9.
1992: Mark N Levine; Vivien H C Bramwell; Hakam Abu-Zahra; M D Goodyear; Andrew Arnold; Brian Findlay; J Skillings; M Gent
The effect of systemic adjuvant chemotherapy on local breast recurrence in node positive breast cancer patients treated by lumpectomy without radiation.
British journal of cancer 1992;65(1):130-2.
1992: Mark N Levine; Vivien H C Bramwell; K Pritchard; D Perrault; Brian Findlay; Hakam Abu-Zahra; David Warr; Andrew Arnold; J Skillings
A pilot study of intensive cyclophosphamide, epirubicin and fluorouracil in patients with axillary node positive or locally advanced breast cancer.
European journal of cancer (Oxford, England : 1990) 1992;29A(1):37-43.
1991: JJ Rusthoven; Joseph L Pater; L Kaizer; K Wilson; David Osoba; Jean Latreille; Brian Findlay; WS Lofters; David Warr; Francis Laberge
A randomized, double-blinded study comparing six doses of batanopride (BMY-25801) with methylprednisolone in patients receiving moderately emetogenic chemotherapy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1991;2(9):681-6.
1990: Mark N Levine; M Gent; W M Hryniuk; Vivien H C Bramwell; Hakam Abu-Zahra; S DePauw; Andrew Arnold; Brian Findlay; L Levin; J Skillings
A randomized trial comparing 12 weeks versus 36 weeks of adjuvant chemotherapy in stage II breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(7):1217-25.
1990: A Figueredo; Andrew Arnold; M Goodyear; Brian Findlay; A Neville; R Normandeau; A Jones
Addition of verapamil and tamoxifen to the initial chemotherapy of small cell lung cancer. A phase I/II study.
Cancer 1990;65(9):1895-902.
1988: Mark N Levine; G H Guyatt; M Gent; S De Pauw; M D Goodyear; W M Hryniuk; Andrew Arnold; Brian Findlay; J R Skillings; Vivien H C Bramwell
Quality of life in stage II breast cancer: an instrument for clinical trials.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1988;6(12):1798-810.